183 related articles for article (PubMed ID: 18297448)
1. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis.
Shigehara K; Miyagi T; Nakashima T; Shimamura M
J Infect Chemother; 2008 Feb; 14(1):40-3. PubMed ID: 18297448
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.
Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A
J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193
[TBL] [Abstract][Full Text] [Related]
4. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
[TBL] [Abstract][Full Text] [Related]
5. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor.
Mosharafa AA; Torky MH; El Said WM; Meshref A
Urology; 2011 Sep; 78(3):511-4. PubMed ID: 21782225
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
Shigemura K; Yasufuku T; Yamashita M; Arakawa S; Fujisawa M
Int J Urol; 2009 Sep; 16(9):723-5. PubMed ID: 19638042
[TBL] [Abstract][Full Text] [Related]
7. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature.
Miura T; Tanaka K; Shigemura K; Nakano Y; Takenaka A; Fujisawa M
Int J Urol; 2008 May; 15(5):457-9. PubMed ID: 18452466
[TBL] [Abstract][Full Text] [Related]
9. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.
Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H
Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546
[TBL] [Abstract][Full Text] [Related]
10. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
Ekici S; Cengiz M; Turan G; Alış EE
Int Urol Nephrol; 2012 Feb; 44(1):19-27. PubMed ID: 21547465
[TBL] [Abstract][Full Text] [Related]
12. Clinical and microbiological characteristics of spontaneous acute prostatitis and transrectal prostate biopsy-related acute prostatitis: Is transrectal prostate biopsy-related acute prostatitis a distinct acute prostatitis category?
Kim JW; Oh MM; Bae JH; Kang SH; Park HS; Moon du G
J Infect Chemother; 2015 Jun; 21(6):434-7. PubMed ID: 25701308
[TBL] [Abstract][Full Text] [Related]
13. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
[TBL] [Abstract][Full Text] [Related]
14. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E
PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053
[TBL] [Abstract][Full Text] [Related]
15. Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases.
Balaban M; Ozkaptan O; Sevinc C; Boz MY; Horuz R; Kafkasli A; Canguven O
Int Braz J Urol; 2020; 46(1):60-66. PubMed ID: 31851459
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle Biopsy.
Miyazaki Y; Akamatsu S; Kanamaru S; Kamiyama Y; Sengiku A; Iguchi R; Sano T; Takahashi A; Ito M; Takenawa J; Ito N; Ogura K
Urol J; 2016 Mar; 13(1):2533-40. PubMed ID: 26945658
[TBL] [Abstract][Full Text] [Related]
17. Cephalosporins periprostatic injection: are really effective on infections following prostate biopsy?
Pace G; Carmignani L; Marenghi C; Mombelli G; Bozzini G
Int Urol Nephrol; 2012 Aug; 44(4):1065-70. PubMed ID: 22434340
[TBL] [Abstract][Full Text] [Related]
18. Comparison of levofloxacin-based prophylaxis regimens for transrectal prostate biopsy: a prospective randomized single-center study.
Su R; Wang KY; Zhang D; Yan ZJ; Jiang JH; Ma Q
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):967-971. PubMed ID: 30919151
[TBL] [Abstract][Full Text] [Related]
19. Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis.
Oh MM; Chae JY; Kim JW; Kim JW; Yoon CY; Park MG; Moon du G
Urology; 2013 Jun; 81(6):1209-12. PubMed ID: 23601450
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
